Factor VIII haplotypes frequencies in Tunisian hemophiliacs A

Diagnostic Pathology

Volumn 6, Issue 1, 2011, Pages

  Elmahmoudi, Hejer ^a   Belhedi, Nejla ^a   Jlizi, Asma ^a   Zahra, Kaouther ^b   Meddeb, Balkis ^b   Elgaaied, Amel B A ^a   Gouider, Emna ^b  

^a FACULTÉ DES SCIENCES DE TUNIS   (Tunisia)

^b Hopital Aziza Othmana   (Tunisia)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIBODY; BLOOD CLOTTING FACTOR 8; COAGULATING AGENT; EPITOPE;

ARTICLE; BLOOD; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETICS; HAPLOTYPE; HEMOPHILIA A; HUMAN; IMMUNOLOGY; PHENOTYPE; SINGLE NUCLEOTIDE POLYMORPHISM; TUNISIA;

COAGULANTS; FACTOR VIII; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HEMOPHILIA A; HUMANS; IMMUNODOMINANT EPITOPES; ISOANTIBODIES; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; TUNISIA;

EID: 79958828905     PISSN: None     EISSN: 17461596     Source Type: Journal    
DOI: 10.1186/1746-1596-6-54     Document Type: Article

References (15)

1. Lin Y, Yang X, Chevrier MC, Craven S, Barrowcliffe TW, Lemieux R, Ofosu FA. Relationships between factor VIII:Ag and factor VIII in recombinant and plasma-derived factor VIII concentrates. Haemophilia 2004, 10:459-469. 10.1111/j.1365-2516.2004.00957.x, 15357771.
2. Wight J, Paisley S. The epidemiology of inhibitors in haemophilia A: a systematic review. Haemophilia 2003, 9:418-35. 10.1046/j.1365-2516.2003.00780.x, 12828678.
3. Viel KR, Machiah DK, Warren DM, Khachidze M, Buil A, Fernstrom K, Souto JC, Peralta JM, Smith T, Blangero J, Porter S, Warren ST, Fontcuberta J, Soria JM, Dana Flanders W, Almasy L, Howard TE. A sequence variation scan of the coagulation factor VIII (FVIII) structural gene and associations with plasma FVIII activity levels. Blood 2007, 109:3713-24. 10.1182/blood-2006-06-026104, 1874571, 17209060.
4. Gitschier J, Wood WI, Goralka TM, Wion KL, Chen EY, Eaton DH, Vehar GA, Capon DJ, Lawn RM. Characterization of the human factor VIII gene. Nature 1984, 312:326-330. 10.1038/312326a0, 6438525.
5. Thompson AR. Structure and function of the factor VIII gene and protein. Semin Thromb Hemost 2003, 29:11-22. 10.1055/s-2003-37935, 12640560.
6. Burke RL, Pachl C, Quiroga M, Rosenberg S, Haigwood N, Nordfang O, Ezban M. The functional domains of coagulation factor VIII: C. J Biol Chem 1986, 261:12574-12578.
7. Lusher JM, Arkin S, Abildgaard CF, Schwartz RS. Recombinant factor VIII for the treatment of previously untreated patients with hemophilia A: safety, efficacy, and development of inhibitors. N Engl J Med 1993, 328:453-9. 10.1056/NEJM199302183280701, 8421474.
8. Bray GL, Gomperts ED, Courter S, Gruppo R, Gordon EM, Manco-Johnson M, Shapiro A, Scheibel E, White G, Lee M. A multicenter study of recombinant factor VIII (Recombinate): safety, efficacy, and inhibitor risk in previously untreated patients with hemophilia A. Blood 1994, 83:2428-35.
9. Viel KR, Ameri A, Abshire TC, Iyer RV, Watts RG, Lutcher C, Channell C, Cole SA, Fernstrom KM, Nakaya S, Kasper CK, Thompson AR, Almasy L, Howard TE. Inhibitors of factor VIII in black patients with hemophilia. N Engl J Med 2009, 360:1618-27. 10.1056/NEJMoa075760, 2761028, 19369668.
10. World Federation of Hemophilia Report on the Annual Global Survey. Canada. 2007,
11. Fadhlaoui-Zid K, Dugoujon JM, Elgaaied A, Amor MB, Yacoubi B, Elkhil HK, Sanchez-Mazas A. Genetic diversity in Tunisia: a study based on the GM polymorphism of human immunoglobulins. Hum Biol 2004, 76:559-67. 10.1353/hub.2004.0054, 15754972.
12. Jlizi A, Edouard J, Fadhlaoui-Zid K, Frigi S, Debré P, Slim A, Theodorou I, El Gaaied AB, Carpentier W. Identification of the CCR5-Delta32 HIV resistance allele and new mutations of the CCR5 gene in different Tunisian populations. Hum Immunol 2007, 68:993-1000. 10.1016/j.humimm.2007.10.003, 18191728.
13. Oldenburg J, Schroder J, Brackmann HH, Muller-Reible C, Schwaab R, Tuddenham E. Environmental and genetic factors influencing inhibitor development. Semin Hematol 2004, 41:82-8.
14. Howard TE, Machiah DK, Tran TT, Viel KR, Howard TE, Deepa M, Channell C, Soria JM, Ameri A, Iyer RV, Brown C, Doering C, Almasy L, Watts R, Davis J, Abshire TC. African-Americans express multiple haplotypic forms of the wildtype factor VIII (FVIII) protein: a possible role for pharmacogenetics in FVIII inhibitor development?. Blood 2004, 104:113.
15. Aledort LM, Dimichele DM. Inhibitors occur more frequently in African-American and Latino haemophiliacs. Haemophilia 1998, 4:68. 10.1046/j.1365-2516.1998.0146c.x, 9873872.